Company
Paris Brain Institute
Paris Brain Institute is a biomedical research center founded in 2010 dedicated to studying the brain and developing treatments for nervous system diseases. Located within Paris's Pitié-Salpêtrière Hospital, it brings together over 900 international experts across 29 research teams and 12 technology platforms using a translational approach that connects basic discoveries with clinical solutions. The institute combines university-affiliated research units with a private foundation and operates an incubator and clinical investigation center.
Paris Brain Institute is a privately held company operating in the research and development in biotechnology and research sectors, based in France. Leadership tracked by CEOInsider includes Stephanie Debette (CEO).
Leadership
Current
Recent developments
AI summary of recent coverageRecent coverage has focused on Paris Brain Institute's research contributions to understanding neurological conditions through large-scale genetic and proteomic studies. The institute's work has examined plasma protein profiles in Alzheimer's disease across African populations, identified genetic risk factors for white matter changes and brain atrophy, and explored stroke genetics relevant to drug discovery and risk prediction across diverse ancestries. Coverage has also highlighted the institute's role in expanding international academic partnerships, including collaborations with major research universities.
Summarized from the headlines in the sidebar; see each source for the full story.